Ποια είναι η τιμή για Hualan Biological Engineering Inc. (002007)

Η τιμή για Hualan Biological Engineering Inc. (002007) είναι $1.92

Ποια είναι η κεφαλαιοποίηση αγοράς για Hualan Biological Engineering Inc. (002007)

Η κεφαλαιοποίηση αγοράς για Hualan Biological Engineering Inc. (002007) είναι $3.51B

Hualan Biological Engineering Inc. (002007) Τιμή και Κεφαλαιοποίηση Αγοράς

Hualan Biological Engineering Inc. operates as a biopharmaceutical company, specializing in the research, development, production, and commercialization of a diverse portfolio of medical products within the People's Republic of China. Its offerings span plasma-derived therapies, various viral and bacterial vaccines, recombinant proteins, and other advanced biologics. The company's extensive range of plasma products includes essential components like human albumin, a broad spectrum of human immunoglobulins (such as intravenous, rabies, hepatitis B, and tetanus formulations), and vital coagulation factors like human prothrombin complex and factor VIII. Hualan also provides specialized solutions such as lyophilized human thrombin for external use and surgical fibrin glue. In its vaccine division, Hualan offers critical immunizations, including several influenza vaccines (e.g., split virus, A H1N1, and quadrivalent forms), recombinant hepatitis B vaccine, and ACYW135 meningococcal polysaccharide vaccine. The company actively pursues strategic collaborations with key scientific organizations, most notably the Chinese Academy of Sciences, as well as other esteemed research institutes and enterprises. Established in 1992, Hualan Biological Engineering Inc. is headquartered in Xinxiang, People's Republic of China.

Η τιμή για 002007	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$2,786.82 $3.51B	NVDA	$5.088T	+144,819.64%
$2,535.53 $3.51B	AAPL	$4.629T	+131,752.14%
$2,255.36 $3.51B	GOOG	$4.118T	+117,182.97%
$2,019.35 $3.51B	MSFT	$3.687T	+104,910.07%
$1,533.47 $3.51B	AMZN	$2.800T	+79,643.34%

Η τιμή για 002007

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$2,786.82 $3.51B